Insulin aspart, recombinant Subcutaneous and Tazorac (Tazarotene Cream)
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Tazorac (Tazarotene Cream) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: tazarotene topical
Brand name: Avage, Fabior, Tazorac
Synonyms: Tazorac
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Tazorac (Tazarotene Gel)
- Insulin aspart, recombinant Subcutaneous-Tazorac Cream
- Insulin aspart, recombinant Subcutaneous-Tazorac Topical
- Insulin aspart, recombinant Subcutaneous-Taztia XT
- Insulin aspart, recombinant Subcutaneous-Tbo-filgrastim
- Insulin aspart, recombinant Subcutaneous-Tbo-filgrastim Subcutaneous
- Tazorac (Tazarotene Cream)-Insulin degludec
- Tazorac (Tazarotene Cream)-Insulin Degludec (U-100) Prefilled Pens
- Tazorac (Tazarotene Cream)-Insulin Degludec (U-100) Vials
- Tazorac (Tazarotene Cream)-Insulin Degludec (U-200) Prefilled Pens
- Tazorac (Tazarotene Cream)-Insulin degludec and liraglutide
- Tazorac (Tazarotene Cream)-Insulin degludec and liraglutide Subcutaneous